Annals of Oncology course: part 7 issues—January 2008 to April 2008

About CME in this Journal	Important dates for this Course
About CME in this Journal Accreditation Statement Credit Designation Statement Intended Audience Objectives Faculty Disclosure	Released: June 23, 2008 Expired: June 23, 2009

You require a username and password to take this course. If you have an existing Oxford Journals username and password, you may proceed and take this course by clicking on the 'Take the Course' link below.
If you do not yet have a valid username and password, then you will need to register to obtain one before taking any CME/CE. Please do so by clicking here and following the registration instructions.
Expand and test the knowledge of participants in the following core areas: formaldehyde and cancer risk; HER-2 overexpression/amplification and taxane therapy; enzastaurin in relapsed or refractory mantle cell lymphoma; carboplatin treatment for seminoma of the testis; KRAS status and response to cetuximab; hENT1 and survival in ampullary cancer; ABVD or EVE chemotherapy in stage I/IIA Hodgkin’s lymphoma